crilvastatin: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 22845140 |
CHEMBL ID | 2218880 |
SCHEMBL ID | 9585667 |
MeSH ID | M0218198 |
Synonym |
---|
120551-59-9 |
crilvastatin |
crilvastatina |
l-proline, 5-oxo-, 3,3,5-trimethylcyclohexyl ester |
crilvastatin [usan:inn] |
crilvastatine |
pmd-387 |
unii-d2b8xwk36k |
crilvastatinum [inn-latin] |
5-oxo-l-proline, (+-)-cis-3,3,5-trimethylcyclohexyl ester |
d2b8xwk36k , |
pmd 387 |
crilvastatinum |
crilvastatine [inn-french] |
crilvastatina [inn-spanish] |
CHEMBL2218880 |
cyclopid |
SCHEMBL9585667 |
(3,3,5-trimethylcyclohexyl) (2s)-5-oxopyrrolidine-2-carboxylate |
3,3,5-trimethylcyclohexyl (2s)-5-oxopyrrolidine-2-carboxylate |
DTXSID101009438 |
AKOS040746723 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |